TY  - JOUR
AU  - Gray, Jhanelle E
AU  - Okamoto, Isamu
AU  - Sriuranpong, Virote
AU  - Vansteenkiste, Johan
AU  - Imamura, Fumio
AU  - Lee, Jong Seok
AU  - Pang, Yong-Kek
AU  - Cobo, Manuel
AU  - Kasahara, Kazuo
AU  - Cheng, Ying
AU  - Nogami, Naoyuki
AU  - Cho, Eun Kyung
AU  - Su, Wu Chou
AU  - Zhang, Guili
AU  - Huang, Xiangning
AU  - Li-Sucholeiki, Xiaocheng
AU  - Lentrichia, Brian
AU  - Dearden, Simon
AU  - Jenkins, Suzanne
AU  - Saggese, Matilde
AU  - Rukazenkov, Yuri
AU  - Ramalingam, Suresh S
PY  - 2019
DO  - 10.1158/1078-0432.CCR-19-1126
UR  - http://hdl.handle.net/10668/14431
T2  - Clinical cancer research : an official journal of the American Association for Cancer Research
AB  - To assess the utility of the cobas EGFR Mutation Test, with tissue and plasma, for first-line osimertinib therapy for patients with EGFR-mutated (EGFRm; Ex19del and/or L858R) advanced or metastatic non-small cell lung cancer (NSCLC) from the FLAURA...
LA  - en
PB  - American Association for Cancer Research
KW  - Acrylamides
KW  - Alleles
KW  - Amino Acid Substitution
KW  - Aniline Compounds
KW  - Antineoplastic Agents
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Clinical Decision-Making
KW  - Acrylamides
KW  - Alleles
KW  - Amino Acid Substitution
KW  - Aniline Compounds
KW  - Antineoplastic Agents
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Clinical Decision-Making
KW  - Clinical Trials, Phase III as Topic
KW  - Disease Management
KW  - ErbB Receptors
KW  - Female
KW  - Humans
KW  - Lung Neoplasms
KW  - Male
KW  - Mutation
KW  - Neoplasm Metastasis
KW  - Neoplasm Staging
KW  - Protein Kinase Inhibitors
KW  - Randomized Controlled Trials as Topic
KW  - Treatment Outcome
TI  - Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer.
TY  - research article
VL  - 25
ER  -